Menlo Park, CA – According to filings with the U.S. Securities and Exchange Commission, Strateos Inc. is raising $16.5 Million in a new round of investment. Sources indicate as part of senior management Chief Financial Officer, Chris Krueger played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Strateos Inc.

STRATEOS automates chemical, biological and image analysis in a closed loop robotic laboratory, granting our partners the power to accelerate drug discovery programs. Using a combination of robotics, high throughput imaging, automated experimentation analysis, and remote cloud laboratories, STRATEOS enables our pharmaceutical partners to more rapidly measure and alter the impact of drug programs. Join us and help build the future of drug discovery.

To learn more about Strateos Inc., visit http://strateos.com/

Contact:
Chris Krueger, Chief Financial Officer
650-763-8432
https://www.linkedin.com/in/christopher-krueger-3b848/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved